CODEL (Alliance N0577; EORTC 26081/22086 ; NRG 1071; NCIC CEC-2): A Phase III Randomized Intergroup Study for patients (pts) with newly diagnosed 1p/19q codeleted anaplastic glioma. Preliminary analysis of patients treated on the original protocol design with RT vs. RT + concomitant/adjuvant TMZ vs. TMZ alone
- Citation:
- Neuro Oncol vol 17 (suppl 5) v4-v5 abstr ATCT-16
- Meeting Instance:
- SNO 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2880
- Pharmas:
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Kurt Jaeckle Michael Voglebaum Karla Ballman Caterina Giannini Ken Aldape Jane Cerhan Jeffrey Wefel Donald Nordstrom Robert Jenkins Martin Klein Jeffrey Raizer Martin van den Bent Wolfgang Wick Patrick Flynn Frederick Dhermain Gregory Cairncross Paul Brown
- Networks:
- FL065, IA085, LAPS-IL036, LAPS-MN026, LAPS-TX035, MN017, MN022
- Study
- NCCTG-N0577
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: